Cargando…

LBODP062 SGLT2 Inhibition Ameliorates Cognitive And Physical Impairment In Patients With HFpEF And Diabetes

AIM: The aim of this study was to assess whether the inhibitor of sodium-glucose cotransporter-2 (SGLT2) empagliflozin improves cognitive impairment in frail older adults with diabetes mellitus (DM) and Heart Failure with Preserved Ejection Fraction (HFpEF). METHODS: We designed a prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mone, Pasquale, Lombardi, Angela, Frullone, Salvatore, Santulli, Gaetano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629380/ http://dx.doi.org/10.1210/jendso/bvac150.572

Ejemplares similares

Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)

LBODP046 Reduction In "Cardiovascular Death Or Hospitalisation For Heart Failure" With Sglt-2is Is Dependent On Weight Reduction: A Meta-regression Analysis
por: Ghosal, Samit, et al.
Publicado: (2022)

LBODP041 Effects Of Sodium-glucose Co-transporter 2 Inhibitors (sglt-2 Inhibitors) On Adipokines And Inflammatory Biomarkers In Type2 Diabetic Patients
por: Kumtree, Phonphruet
Publicado: (2022)

LBODP035 When Is Ketosis Just Ketosis?
por: Cannon, Sophie M, et al.
Publicado: (2022)

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
por: Bode, David, et al.
Publicado: (2021)

SGLT2 inhibitors in patients with HFpEF: how old is too old?
por: Tong, Dan
Publicado: (2022)

LBODP033 The Compliant Patient - When Adherence Hurts
por: Cheah, Zhen Fung, et al.
Publicado: (2022)

LBODP039 Glycogenic Hepatopathy- An Underrecognized Complication Of Diabetes
por: Chamakkala, Tess, et al.
Publicado: (2022)

Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022)

LBODP043 Analysis Of Plastic Surgery Websites And Their Recommendations For Diabetics
por: Levine, Emma C, et al.
Publicado: (2022)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

LBODP034 Metformin Associated Lactic Acidosis, Rare But Real
por: Khalifa, Maram, et al.
Publicado: (2022)

Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021)

LBODP048 Barriers To Diabetic Retinopathy Screening In Hospitalized Patients With Diabetes
por: Kumar, Monisha, et al.
Publicado: (2022)

LBODP031 Evaluation Of Artifactual Hypoglycemia: A Case-based Review
por: Mohammed ALShehri, Sara, et al.
Publicado: (2022)

LBODP054 Hypogonadism in Diabetes Mellitus: Insulin Resistance, The Connecting Link?
por: Singh, Jaspreet, et al.
Publicado: (2022)

Diet-Induced Obesity HFpEF Murine Models
por: Carbone, Salvatore, et al.
Publicado: (2018)

Impaired Myocardial Bioenergetics in HFpEF and the Role of Antioxidants
por: Hiebert, John B., et al.
Publicado: (2016)

LBODP050 Examination Of The Effectiveness Of Diabetic Nephropathy Treatment Targeting Chrebp Activity
por: Suzuki, Susumu, et al.
Publicado: (2022)

LBODP036 A Case of Euglycemic Diabetic Ketoacidosis After Distal Pancreatectomy
por: Turner, James, et al.
Publicado: (2022)

LBODP040 Positive Early Glucola Screening: Who Has Gestational Diabetes?
por: Class, Madelyn, et al.
Publicado: (2022)

LBODP019 Vitamin D Levels In A Population With Type 2 Diabetes
por: Elias, Natalia Olga, et al.
Publicado: (2022)

LBODP053 Significance Of Insulin Resistance And Development Of Type 2 Diabetes Mellitus
por: Rusalenka, Mariya, et al.
Publicado: (2022)

LBODP055 Discrimination Effectiveness Of Radiofrequency Echographic Multispectrometry As Non Invasive Method For Osteoporosis Diagnosis Applied To Elderly Women With Type 2 Diabetes
por: Caffarelli, Carla, et al.
Publicado: (2022)

New aspects in cardiorenal syndrome and HFpEF
por: Méndez, Ana Belén, et al.
Publicado: (2022)

LBODP049 Clinical And Biochemical Markers In Early Pregnancy For Prediction Of Gestational Diabetes Mellitus
por: Manglunia, Ankit, et al.
Publicado: (2022)

LBODP061 A Pilot Trial Of Continuous Glucose Monitoring Technology In The Perioperative Period
por: Price, Catherine E, et al.
Publicado: (2022)

LBODP060 Abnormal Endothelial Dysfunction Is Already Present Among Individuals With Pre-impaired Glucose Tolerance (Pre-IGT)
por: Salmon, Jeannine Ann O, et al.
Publicado: (2022)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
por: Mangner, Norman, et al.
Publicado: (2023)

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023)

LBODP066 A Conservative Approach To The Management Of Glucagon Receptor (GCCR) Mutation (Mahvash Syndrome)
por: Morgenthau, Ari, et al.
Publicado: (2022)

LBODP038 Metformin-Associated Severe Lactic Acidosis: A Case Study Of The Perfect Storm
por: Maki, Marwa K, et al.
Publicado: (2022)

LBODP057 Association Between DKA And Live Abscess: Results From The National Inpatient Sample
por: Muammar, Ahmad, et al.
Publicado: (2022)

LBODP056 Factors That Associate With Under-diagnosing Prediabetes In Primary Care: A Retrospective Study
por: Nguyen, An V, et al.
Publicado: (2022)

SAT062 Inhibition Of GIPR Expression Enhances Sulfonylurea-induced Insulin Secretion, And It Was Associated With Changes In ATP Contents
por: Ah Kim, Hyun, et al.
Publicado: (2023)

Left-Side Pressure Index for All-Cause Mortality in Older Adults with HFpEF: Diagnostic Potential for HFpEF and Possible View for HFrEF
por: Hoshida, Shiro
Publicado: (2023)

LBODP058 Evaluation Of Factors Associated With The Development Of Diabetic Retinopathy Based On A Case-control Study
por: Nathani, Pratiksha Shankarlal, et al.
Publicado: (2022)

Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial
por: Backhaus, Sören J., et al.
Publicado: (2022)

LBODP037 Acute Foot Drop In An Adolescent With Type 1 Diabetes Mellitus At Onset: A Case Report
por: Albasri, Eman Ebrahim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkm1qupsti5nv8ufecnsgt4415